Aquarius Surgical Technologies Inc.
AQQRF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -55.6% | 0.7% | -37.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 51.9% | 64.7% | 36.4% | 24.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $0 | $1 |
| Operating Income | -$1 | -$0 | -$1 | -$1 |
| % Margin | -598.2% | -223.5% | -316.1% | -209.8% |
| Other Income/Exp. Net | -$1 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -1,279.8% | -369.1% | -355.1% | -262.2% |
| EPS | -0.04 | -0.028 | -0.029 | -0.037 |
| % Growth | -45.5% | 5.5% | 21.8% | – |
| EPS Diluted | -0.04 | -0.028 | -0.029 | -0.037 |
| Weighted Avg Shares Out | 28 | 28 | 25 | 23 |
| Weighted Avg Shares Out Dil | 28 | 28 | 25 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$0 | -$1 | -$1 |
| % Margin | -913.1% | -209.4% | -253.9% | -194.2% |